-
1
-
-
0031037437
-
Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: A comparison by site and correlation with clinical information
-
Artenstein, A. W., T. C. VanCott, K. V. Sitz, M. L. Robb, K. F. Wagner, S. C. D. Veit, A. B. Rogers, R. P. Garner, J. W. Byron, P. R. Burnett, and D. L. Birx. 1997. Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information. J. Infect. Dis. 175:265-271.
-
(1997)
J. Infect. Dis.
, vol.175
, pp. 265-271
-
-
Artenstein, A.W.1
VanCott, T.C.2
Sitz, K.V.3
Robb, M.L.4
Wagner, K.F.5
Veit, S.C.D.6
Rogers, A.B.7
Garner, R.P.8
Byron, J.W.9
Burnett, P.R.10
Birx, D.L.11
-
2
-
-
0028024901
-
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network
-
Belshe, R. B., B. S. Graham, M. C. Keefer, G. J. Gorse, P. Wright, R. Dolin, T. Matthews, K. Weinhold, D. P. Bolognesi, R. Sposto, D. M. Stablein, T. Twadell, P. W. Berman, T. Gregory, A. E. Izu, M. C. Walker, and P. Fast. 1994. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network. JAMA 272:475-480.
-
(1994)
JAMA
, vol.272
, pp. 475-480
-
-
Belshe, R.B.1
Graham, B.S.2
Keefer, M.C.3
Gorse, G.J.4
Wright, P.5
Dolin, R.6
Matthews, T.7
Weinhold, K.8
Bolognesi, D.P.9
Sposto, R.10
Stablein, D.M.11
Twadell, T.12
Berman, P.W.13
Gregory, T.14
Izu, A.E.15
Walker, M.C.16
Fast, P.17
-
3
-
-
0025932084
-
A predominant group-specific neutralizing epitope of human immunodeficiency virus type 1 maps to residues 342 to 511 of the envelope glycoproptein gp120
-
Berkower, I., D. Murphy, C. C. Smith, and G. E. Smith. 1991. A predominant group-specific neutralizing epitope of human immunodeficiency virus type 1 maps to residues 342 to 511 of the envelope glycoproptein gp120. J. Virol. 65:5983-5990.
-
(1991)
J. Virol.
, vol.65
, pp. 5983-5990
-
-
Berkower, I.1
Murphy, D.2
Smith, C.C.3
Smith, G.E.4
-
4
-
-
0025331727
-
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160
-
Berman, P. W., T. J. Gregory, L. Riddle, G. R. Nakamura, M. A. Champe, J. P. Porter, F. M. Wurm, R. D. Hershberg, E. K. Cobb, and J. W. Eichberg. 1990. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 345:622-625.
-
(1990)
Nature
, vol.345
, pp. 622-625
-
-
Berman, P.W.1
Gregory, T.J.2
Riddle, L.3
Nakamura, G.R.4
Champe, M.A.5
Porter, J.P.6
Wurm, F.M.7
Hershberg, R.D.8
Cobb, E.K.9
Eichberg, J.W.10
-
5
-
-
0029996017
-
Inhibition of human immunodeficiency virus type 1 production in infected peripheral blood mononuclear cells by human leukocyte antigen class I-specific antibodies: Evidence for a novel antiviral mechanism
-
Briant, L., M. Benkirane, M. Girard, M. Hirn, C. Iosef, and C. Devaux. 1996. Inhibition of human immunodeficiency virus type 1 production in infected peripheral blood mononuclear cells by human leukocyte antigen class I-specific antibodies: evidence for a novel antiviral mechanism. J. Virol. 70:5213-5220.
-
(1996)
J. Virol.
, vol.70
, pp. 5213-5220
-
-
Briant, L.1
Benkirane, M.2
Girard, M.3
Hirn, M.4
Iosef, C.5
Devaux, C.6
-
6
-
-
0026536582
-
Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins
-
Broliden, P. A., G. A. von, P. Clapham, J. Rosen, E. M. Fenyo, B. Wahren, and K. Broliden. 1992. Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc. Natl. Acad. Sci. USA 89:461-465.
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 461-465
-
-
Broliden, P.A.1
Von, G.A.2
Clapham, P.3
Rosen, J.4
Fenyo, E.M.5
Wahren, B.6
Broliden, K.7
-
7
-
-
0030448190
-
Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults
-
Bruguera, M., J. M. Bayas, A. Vilella, C. Tural, A. Gonzalez, J. Vidal, R. Dal-Re, and L. Salleras. 1996. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults. Vaccine 14:1407-1411.
-
(1996)
Vaccine
, vol.14
, pp. 1407-1411
-
-
Bruguera, M.1
Bayas, J.M.2
Vilella, A.3
Tural, C.4
Gonzalez, A.5
Vidal, J.6
Dal-Re, R.7
Salleras, L.8
-
8
-
-
0031047826
-
A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE
-
Buratti, E., S. G. Tisminetzky, P. D'Agaro, and F. E. Baralle. 1997. A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE. J. Virol. 71:2457-2462.
-
(1997)
J. Virol.
, vol.71
, pp. 2457-2462
-
-
Buratti, E.1
Tisminetzky, S.G.2
D'Agaro, P.3
Baralle, F.E.4
-
9
-
-
0027985431
-
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
-
Burton, D. R., J. Pyati, R. Koduri, S. J. Sharp, G. B. Thornton, P. W. Parren, L. S. Sawyer, R. M. Hendry, N. Dunlop, P. L. Nara, M. Lamacchia, E. Garratty, E. R. Stiehm, Y. J. Bryson, Y. Cao, J. P. Moore, D. D. Ho, and C. F. Barbas. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024-1027.
-
(1994)
Science
, vol.266
, pp. 1024-1027
-
-
Burton, D.R.1
Pyati, J.2
Koduri, R.3
Sharp, S.J.4
Thornton, G.B.5
Parren, P.W.6
Sawyer, L.S.7
Hendry, R.M.8
Dunlop, N.9
Nara, P.L.10
Lamacchia, M.11
Garratty, E.12
Stiehm, E.R.13
Bryson, Y.J.14
Cao, Y.15
Moore, J.P.16
Ho, D.D.17
Barbas, C.F.18
-
10
-
-
0028847578
-
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
-
Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
-
(1995)
N. Engl. J. Med.
, vol.332
, pp. 201-208
-
-
Cao, Y.1
Qin, L.2
Zhang, L.3
Safrit, J.4
Ho, D.D.5
-
11
-
-
0029032565
-
Return to the past: The case for antibody-based therapies in infectious diseases
-
Casadevall, A., and M. D. Scharff. 1995. Return to the past: the case for antibody-based therapies in infectious diseases. Clin. Infect. Dis. 21:150-161.
-
(1995)
Clin. Infect. Dis.
, vol.21
, pp. 150-161
-
-
Casadevall, A.1
Scharff, M.D.2
-
12
-
-
0025089766
-
Measles antibody: Reevaluation of protective titers
-
Chen, R. T., L. E. Markowitz, P. Albrecht, J. A. Stewart, L. M. Mofenson, S. R. Preblud, and W. A. Orenstein. 1990. Measles antibody: reevaluation of protective titers. J. Infect. Dis. 162:1036-1042.
-
(1990)
J. Infect. Dis.
, vol.162
, pp. 1036-1042
-
-
Chen, R.T.1
Markowitz, L.E.2
Albrecht, P.3
Stewart, J.A.4
Mofenson, L.M.5
Preblud, S.R.6
Orenstein, W.A.7
-
13
-
-
0029417004
-
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
-
Cocchi, F., A. L. De Vico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811-1815.
-
(1995)
Science
, vol.270
, pp. 1811-1815
-
-
Cocchi, F.1
De Vico, A.L.2
Garzino-Demo, A.3
Arya, S.K.4
Gallo, R.C.5
Lusso, P.6
-
14
-
-
0028208268
-
Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, and anti-gp41 human monoclonal antibody
-
Conley, A. J., J. N. Kessler, L. J. Boots, J. S. Tung, B. A. Arnold, P. M. Keller, A. R. Shaw, and E. A. Emini. 1994. Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, and anti-gp41 human monoclonal antibody. Proc. Natl. Acad. Sci. USA 91:3348-3352.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 3348-3352
-
-
Conley, A.J.1
Kessler, J.N.2
Boots, L.J.3
Tung, J.S.4
Arnold, B.A.5
Keller, P.M.6
Shaw, A.R.7
Emini, E.A.8
-
15
-
-
0030035109
-
A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates
-
Cotropia, J., K. E. Ugen, S. Kliks, K. Broliden, P. A. Broliden, J. A. Hoxie, V. Srikantan, W. V. Williams, and D. B. Weiner. 1996. A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 12:221-232.
-
(1996)
J. Acquired Immune Defic. Syndr. Hum. Retrovirol.
, vol.12
, pp. 221-232
-
-
Cotropia, J.1
Ugen, K.E.2
Kliks, S.3
Broliden, K.4
Broliden, P.A.5
Hoxie, J.A.6
Srikantan, V.7
Williams, W.V.8
Weiner, D.B.9
-
16
-
-
0026012053
-
Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors
-
Cummins, L. M., K. J. Weinhold, T. J. Matthews, A. J. Langlois, C. F. Perno, R. M. Condie, and J. P. Allain. 1991. Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors. Blood 77:1111-1117.
-
(1991)
Blood
, vol.77
, pp. 1111-1117
-
-
Cummins, L.M.1
Weinhold, K.J.2
Matthews, T.J.3
Langlois, A.J.4
Perno, C.F.5
Condie, R.M.6
Allain, J.P.7
-
17
-
-
0029927680
-
Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates
-
De Vico, A., A. Silver, A. M. Thronton, M. G. Sarngadharan, and R. Pal. 1996. Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates. Virology 218:258-263.
-
(1996)
Virology
, vol.218
, pp. 258-263
-
-
De Vico, A.1
Silver, A.2
Thronton, A.M.3
Sarngadharan, M.G.4
Pal, R.5
-
18
-
-
0029123163
-
Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120
-
De Vico, A. L., R. Rahman, J. Welch, R. Crowley, P. Lusso, M. G. Sarngadharan, and R. Pal. 1995. Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120. Virology 211:583-588.
-
(1995)
Virology
, vol.211
, pp. 583-588
-
-
De Vico, A.L.1
Rahman, R.2
Welch, J.3
Crowley, R.4
Lusso, P.5
Sarngadharan, M.G.6
Pal, R.7
-
19
-
-
0030997127
-
Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein
-
Earl, P. L., C. C. Broder, R. W. Doms, and B. Moss. 1997. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein. J. Virol. 71:2674-2684.
-
(1997)
J. Virol.
, vol.71
, pp. 2674-2684
-
-
Earl, P.L.1
Broder, C.C.2
Doms, R.W.3
Moss, B.4
-
20
-
-
0028355456
-
Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities
-
Earl, P. L., C. C. Broder, D. Long, S. A. Lee, J. Peterson, S. Chakrabarti, R. W. Doms, and B. Moss. 1994. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol. 68:3015-3026.
-
(1994)
J. Virol.
, vol.68
, pp. 3015-3026
-
-
Earl, P.L.1
Broder, C.C.2
Long, D.3
Lee, S.A.4
Peterson, J.5
Chakrabarti, S.6
Doms, R.W.7
Moss, B.8
-
21
-
-
0025095635
-
Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein
-
Earl, P. L., R. W. Doms, and B. Moss. 1990. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 87:648-652.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 648-652
-
-
Earl, P.L.1
Doms, R.W.2
Moss, B.3
-
22
-
-
0030897825
-
Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
-
Fouts, T. R., J. M. Binley, A. Trkola, J. E. Robinson, and J. P. Moore. 1997. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 71:2779-2785.
-
(1997)
J. Virol.
, vol.71
, pp. 2779-2785
-
-
Fouts, T.R.1
Binley, J.M.2
Trkola, A.3
Robinson, J.E.4
Moore, J.P.5
-
23
-
-
0020513490
-
Influenza B virus infections in the community and the family. The epidemics of 1976-1977 and 1979-1980 in Houston, Texas
-
Frank, A. L., L. H. Taber, W. P. Glezen, E. A. Geyer, S. McIlwain, and A. Paredes. 1983. Influenza B virus infections in the community and the family. The epidemics of 1976-1977 and 1979-1980 in Houston, Texas. Am. J. Epidemiol. 118:313-325.
-
(1983)
Am. J. Epidemiol.
, vol.118
, pp. 313-325
-
-
Frank, A.L.1
Taber, L.H.2
Glezen, W.P.3
Geyer, E.A.4
McIlwain, S.5
Paredes, A.6
-
24
-
-
0027324106
-
HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex
-
Gershoni, J., G. Denisova, D. Raviv, N. Smorodinsky, and D. Buyaner. 1993. HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex. FASEB J. 7:1185-1187.
-
(1993)
FASEB J.
, vol.7
, pp. 1185-1187
-
-
Gershoni, J.1
Denisova, G.2
Raviv, D.3
Smorodinsky, N.4
Buyaner, D.5
-
25
-
-
0029012807
-
Antibody to adhesion molecule LFA-1 enhances plasma neutralization of human immunodeficiency virus type 1
-
Gomez, M. B., and J. E. Hildreth. 1995. Antibody to adhesion molecule LFA-1 enhances plasma neutralization of human immunodeficiency virus type 1. J. Virol. 69:4628-4632.
-
(1995)
J. Virol.
, vol.69
, pp. 4628-4632
-
-
Gomez, M.B.1
Hildreth, J.E.2
-
26
-
-
0028027741
-
Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1
-
Gorny, M. K., J. P. Moore, A. J. Conley, S. Karwowska, J. Sodroski, C. Williams, S. Burda, L. J. Boots, and P. S. Zolla. 1994. Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1. J. Virol. 68:8312-8320.
-
(1994)
J. Virol.
, vol.68
, pp. 8312-8320
-
-
Gorny, M.K.1
Moore, J.P.2
Conley, A.J.3
Karwowska, S.4
Sodroski, J.5
Williams, C.6
Burda, S.7
Boots, L.J.8
Zolla, P.S.9
-
27
-
-
0027384670
-
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children
-
The Respiratory Syncytial Virus Immune Globulin Study Group
-
Groothuis, J. R., E. A. Simoes, M. J. Levin, C. B. Hall, C. E. Long, W. J. Rodriguez, J. Arrobio, H. C. Meissner, D. R. Fulton, R. C. Welliver, et al. 1993. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N. Engl. J. Med. 329:1524-1530.
-
(1993)
N. Engl. J. Med.
, vol.329
, pp. 1524-1530
-
-
Groothuis, J.R.1
Simoes, E.A.2
Levin, M.J.3
Hall, C.B.4
Long, C.E.5
Rodriguez, W.J.6
Arrobio, J.7
Meissner, H.C.8
Fulton, D.R.9
Welliver, R.C.10
-
28
-
-
0023818748
-
Pathogenesis of dengue: Challenges to molecular biology
-
Halstead, S. B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
-
(1988)
Science
, vol.239
, pp. 476-481
-
-
Halstead, S.B.1
-
29
-
-
0001606030
-
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis
-
Hammon, W. M., L. L. Coriel, and P. F. Wehrle. 1953. Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. JAMA 151:1272-1285.
-
(1953)
JAMA
, vol.151
, pp. 1272-1285
-
-
Hammon, W.M.1
Coriel, L.L.2
Wehrle, P.F.3
-
30
-
-
0028449193
-
Measuring vaccine-induced HIV neutralization: Report of a workshop
-
Hanson, C. V. 1994. Measuring vaccine-induced HIV neutralization: report of a workshop. AIDS Res. Hum. Retroviruses 10:645-648.
-
(1994)
AIDS Res. Hum. Retroviruses
, vol.10
, pp. 645-648
-
-
Hanson, C.V.1
-
31
-
-
0023182368
-
Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins
-
Ho, D. D., M. G. Sarngadharan, M. S. Hirsch, R. T. Schooley, T. R. Rota, R. C. Kennedy, T. C. Chanh, and V. L. Sato. 1987. Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J. Virol. 61:2024-2028.
-
(1987)
J. Virol.
, vol.61
, pp. 2024-2028
-
-
Ho, D.D.1
Sarngadharan, M.G.2
Hirsch, M.S.3
Schooley, R.T.4
Rota, T.R.5
Kennedy, R.C.6
Chanh, T.C.7
Sato, V.L.8
-
32
-
-
16144364048
-
Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17
-
Kageyama, S., T. Katsumoto, K. Taniguchi, S. I. Ismail, T. Shimmen, F. Sasao, M. Gao, S. Owatari, N. Wakamiya, H. Tsuchie, S. Ueda K. Shiraki, and T. Kurimura. 1996. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17. Acta Virol. 40:195-200.
-
(1996)
Acta Virol.
, vol.40
, pp. 195-200
-
-
Kageyama, S.1
Katsumoto, T.2
Taniguchi, K.3
Ismail, S.I.4
Shimmen, T.5
Sasao, F.6
Gao, M.7
Owatari, S.8
Wakamiya, N.9
Tsuchie, H.10
Ueda, S.11
Shiraki, K.12
Kurimura, T.13
-
33
-
-
0027988552
-
Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers
-
Kahn, J. O., F. Sinangil, J. Baenziger, N. Murcar, D. Wynne, R. L. Coleman, K. S. Steimer, C. L. Dekker, and D. Chernoff. 1994. Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers. J. Infect. Dis. 170:1288-1291.
-
(1994)
J. Infect. Dis.
, vol.170
, pp. 1288-1291
-
-
Kahn, J.O.1
Sinangil, F.2
Baenziger, J.3
Murcar, N.4
Wynne, D.5
Coleman, R.L.6
Steimer, K.S.7
Dekker, C.L.8
Chernoff, D.9
-
34
-
-
0026000541
-
Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules
-
Kalter, D. C., H. E. Gendelman, and M. S. Meltzer. 1991. Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules. Immunol. Lett. 30:219-227.
-
(1991)
Immunol. Lett.
, vol.30
, pp. 219-227
-
-
Kalter, D.C.1
Gendelman, H.E.2
Meltzer, M.S.3
-
35
-
-
0023696997
-
A unique human immunodeficiency virus culture secreting soluble gp160
-
Kalyanaraman, V. S., R. Pal, R. C. Gallo, and G. Sarngadharan. 1988. A unique human immunodeficiency virus culture secreting soluble gp160. AIDS Res. Hum. Retroviruses 4:319-329.
-
(1988)
AIDS Res. Hum. Retroviruses
, vol.4
, pp. 319-329
-
-
Kalyanaraman, V.S.1
Pal, R.2
Gallo, R.C.3
Sarngadharan, G.4
-
36
-
-
0025030582
-
Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1
-
Kalyanaraman, V. S., V. Rodriguez, F. Veronese, R. Rahman, P. Lusso, A. L. DeVico, T. Copeland, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan. 1990. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 6:371-380.
-
(1990)
AIDS Res. Hum. Retroviruses
, vol.6
, pp. 371-380
-
-
Kalyanaraman, V.S.1
Rodriguez, V.2
Veronese, F.3
Rahman, R.4
Lusso, P.5
Devico, A.L.6
Copeland, T.7
Oroszlan, S.8
Gallo, R.C.9
Sarngadharan, M.G.10
-
37
-
-
0025775863
-
Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans
-
Kang, C. Y., P. Nara, S. Chamat, V. Caralli, T. Ryskamp, N. Haigwood, R. Newman, and H. Kohler. 1991. Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proc. Natl. Acad. Sci. USA 88:6171-6175.
-
(1991)
Proc. Natl. Acad. Sci. USA
, vol.88
, pp. 6171-6175
-
-
Kang, C.Y.1
Nara, P.2
Chamat, S.3
Caralli, V.4
Ryskamp, T.5
Haigwood, N.6
Newman, R.7
Kohler, H.8
-
38
-
-
0032543307
-
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
-
Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
-
(1998)
Nature
, vol.393
, pp. 648-659
-
-
Kwong, P.D.1
Wyatt, R.2
Robinson, J.3
Sweet, R.W.4
Sodroski, J.5
Hendrickson, W.A.6
-
39
-
-
0027813097
-
Antigen detection in neutralization assays: High levels of interfering anti-p24 antibodies in some plasma
-
Letter
-
Mascola, J. R., and D. S. Burke. 1993. Antigen detection in neutralization assays: high levels of interfering anti-p24 antibodies in some plasma. AIDS Res. Hum. Retroviruses 9:1173-1174. (Letter.)
-
(1993)
AIDS Res. Hum. Retroviruses
, vol.9
, pp. 1173-1174
-
-
Mascola, J.R.1
Burke, D.S.2
-
40
-
-
0030823325
-
Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12
-
Mascola, J. R., M. K. Louder, T. C. Van Cott, C. V. Sapan, J. S. Lambert, L. R. Muenz, B. Bunow, D. L. Birx, and M. L. Robb. 1997. Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12. J. Virol. 71:7198-7206.
-
(1997)
J. Virol.
, vol.71
, pp. 7198-7206
-
-
Mascola, J.R.1
Louder, M.K.2
Van Cott, T.C.3
Sapan, C.V.4
Lambert, J.S.5
Muenz, L.R.6
Bunow, B.7
Birx, D.L.8
Robb, M.L.9
-
41
-
-
19144365910
-
Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1
-
The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group
-
Mascola, J. R., S. W. Snyder, O. S. Weislow, S. M. Belay, R. B. Belshe, D. H. Schwartz, M. L. Clements, R. Dolin, B. S. Graham, G. J. Gorse, M. C. Keefer, M. J. McElrath, M. C. Walker, K. F. Wagner, J. G. McNeil, F. E. McCutchan and D. S. Burke. 1996. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J. Infect. Dis. 173:340-348.
-
(1996)
J. Infect. Dis.
, vol.173
, pp. 340-348
-
-
Mascola, J.R.1
Snyder, S.W.2
Weislow, O.S.3
Belay, S.M.4
Belshe, R.B.5
Schwartz, D.H.6
Clements, M.L.7
Dolin, R.8
Graham, B.S.9
Gorse, G.J.10
Keefer, M.C.11
McElrath, M.J.12
Walker, M.C.13
Wagner, K.F.14
McNeil, J.G.15
McCutchan, F.E.16
Burke, D.S.17
-
42
-
-
0008547784
-
Serological reactivity from HIV-1 vaccine recipients participating in the AIDS vaccine clinical trials network
-
Matthews, T., C. McDanal, T. Greenwell, A. Streilein, D. Davison, M. Ruland, and D. Bolognesi. 1994. Serological reactivity from HIV-1 vaccine recipients participating in the AIDS vaccine clinical trials network. AIDS Res. Hum. Retroviruses 10:S55.
-
(1994)
AIDS Res. Hum. Retroviruses
, vol.10
-
-
Matthews, T.1
McDanal, C.2
Greenwell, T.3
Streilein, A.4
Davison, D.5
Ruland, M.6
Bolognesi, D.7
-
43
-
-
0022878540
-
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein
-
Matthews, T. J., A. J. Langlois, W. G. Robey, N. T. Chang, R. C. Gallo, P. J. Fischinger and D. P. Bolognesi. 1986. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc. Natl. Acad. Sci. USA 83:9709-9713.
-
(1986)
Proc. Natl. Acad. Sci. USA
, vol.83
, pp. 9709-9713
-
-
Matthews, T.J.1
Langlois, A.J.2
Robey, W.G.3
Chang, N.T.4
Gallo, R.C.5
Fischinger, P.J.6
Bolognesi, D.P.7
-
44
-
-
0030589259
-
Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys
-
Montefiori, D. C., T. W. Baba, A. Li, M. Bilska, and R. M. Ruprecht. 1996. Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys. J. Immunol. 157:5528-5535.
-
(1996)
J. Immunol.
, vol.157
, pp. 5528-5535
-
-
Montefiori, D.C.1
Baba, T.W.2
Li, A.3
Bilska, M.4
Ruprecht, R.M.5
-
45
-
-
0028917784
-
Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120
-
Moore, J. P., Y. Cao, L. Qing, Q. J. Sattentau, J. Pyati, R. Koduri, J. Robinson, C. F. R. Barbas, D. R. Burton, and D. D. Ho. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69:101-109.
-
(1995)
J. Virol.
, vol.69
, pp. 101-109
-
-
Moore, J.P.1
Cao, Y.2
Qing, L.3
Sattentau, Q.J.4
Pyati, J.5
Koduri, R.6
Robinson, J.7
Barbas, C.F.R.8
Burton, D.R.9
Ho, D.D.10
-
46
-
-
0027397052
-
Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans
-
Moore, J. P., and D. D. Ho. 1993. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67:863-875.
-
(1993)
J. Virol.
, vol.67
, pp. 863-875
-
-
Moore, J.P.1
Ho, D.D.2
-
47
-
-
0027378573
-
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
-
Muster, T., F. Steindl, M. Purtscher, A. Trkola, A. Klima, G. Himmler, F. Ruker, and H. Katinger. 1993. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:6642-6647.
-
(1993)
J. Virol.
, vol.67
, pp. 6642-6647
-
-
Muster, T.1
Steindl, F.2
Purtscher, M.3
Trkola, A.4
Klima, A.5
Himmler, G.6
Ruker, F.7
Katinger, H.8
-
48
-
-
0027852353
-
Characterization of murine monoclonal antibodies directed against the submembrane protein p17 of HIV-1
-
Niedrig, M., H. P. Harthus, M. Broker, R. Meloen, H. Gelderblom and G. Pauli. 1993. Characterization of murine monoclonal antibodies directed against the submembrane protein p17 of HIV-1. Hybridoma 12:431-439.
-
(1993)
Hybridoma
, vol.12
, pp. 431-439
-
-
Niedrig, M.1
Harthus, H.P.2
Broker, M.3
Meloen, R.4
Gelderblom, H.5
Pauli, G.6
-
49
-
-
0029861453
-
In vitro antigen challenge of human antibody libraries for vaccine evaluation: The human immunodeficiency virus type 1 envelope
-
Parren, P. W., P. Fisicaro, A. F. Labrijn, J. M. Binley, W. P. Yang, H. J. Ditzel, C. F. R. Barbas, and D. R. Burton. 1996. In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope. J. Virol. 70:9046-9050.
-
(1996)
J. Virol.
, vol.70
, pp. 9046-9050
-
-
Parren, P.W.1
Fisicaro, P.2
Labrijn, A.F.3
Binley, J.M.4
Yang, W.P.5
Ditzel, H.J.6
Barbas, C.F.R.7
Burton, D.R.8
-
50
-
-
0031969423
-
Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity
-
Parren, P. W. H. I., I. Mondor, D. Naniche, H. J. Ditzel, P. J. Klasse, D. R. Burton, and Q. J. Sattentau. 1998. Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity. J. Virol. 72:3512-3519.
-
(1998)
J. Virol.
, vol.72
, pp. 3512-3519
-
-
Parren, P.W.H.I.1
Mondor, I.2
Naniche, D.3
Ditzel, H.J.4
Klasse, P.J.5
Burton, D.R.6
Sattentau, Q.J.7
-
51
-
-
0024327732
-
Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1
-
Pinter, A., W. J. Honnen, S. A. Tilley, C. Bona, H. Zaghouani, M. Gorny, and S. Zolla-Pazner. 1989. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J. Virol. 63:2674-2679.
-
(1989)
J. Virol.
, vol.63
, pp. 2674-2679
-
-
Pinter, A.1
Honnen, W.J.2
Tilley, S.A.3
Bona, C.4
Zaghouani, H.5
Gorny, M.6
Zolla-Pazner, S.7
-
52
-
-
0026001658
-
An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection
-
Posner, M. R., T. Hideshima, T. Cannon, M. Mukherjee, K. H. Mayer, and R. A. Byrn. 1991. An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection. J. Immunol. 146:4325-4332.
-
(1991)
J. Immunol.
, vol.146
, pp. 4325-4332
-
-
Posner, M.R.1
Hideshima, T.2
Cannon, T.3
Mukherjee, M.4
Mayer, K.H.5
Byrn, R.A.6
-
53
-
-
0025292473
-
Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual
-
Profy, A. T., P. A. Salinas, L. I. Eckler, N. M. Dunlop, P. L. Nara, and S. D. Putney. 1990. Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual. J. Immunol. 144:4641-4647.
-
(1990)
J. Immunol.
, vol.144
, pp. 4641-4647
-
-
Profy, A.T.1
Salinas, P.A.2
Eckler, L.I.3
Dunlop, N.M.4
Nara, P.L.5
Putney, S.D.6
-
54
-
-
0030962180
-
Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization
-
Rizzuto, C. D., and J. G. Sodroski. 1997. Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization. J. Virol. 71:4847-4851.
-
(1997)
J. Virol.
, vol.71
, pp. 4847-4851
-
-
Rizzuto, C.D.1
Sodroski, J.G.2
-
55
-
-
0032546952
-
A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
-
Rizzuto, C. D., R. Wyatt, N. Hernandez-Ramos, Y. Sun, P. D. Kwong, W. A. Hendrickson, and J. Sodroski. 1998. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949-1953.
-
(1998)
Science
, vol.280
, pp. 1949-1953
-
-
Rizzuto, C.D.1
Wyatt, R.2
Hernandez-Ramos, N.3
Sun, Y.4
Kwong, P.D.5
Hendrickson, W.A.6
Sodroski, J.7
-
56
-
-
0029310641
-
Perspective: Hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum
-
Robbins, J. B., R. Schneerson, and S. C. Szu. 1995. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1387-1398.
-
(1995)
J. Infect. Dis.
, vol.171
, pp. 1387-1398
-
-
Robbins, J.B.1
Schneerson, R.2
Szu, S.C.3
-
57
-
-
0021840491
-
HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex
-
Robert, G. M., M. Brown, and R. C. Gallo. 1985. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature 316:72-74.
-
(1985)
Nature
, vol.316
, pp. 72-74
-
-
Robert, G.M.1
Brown, M.2
Gallo, R.C.3
-
58
-
-
0025866185
-
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding
-
Sattentau, Q. J., and J. P. Moore. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407-415.
-
(1991)
J. Exp. Med.
, vol.174
, pp. 407-415
-
-
Sattentau, Q.J.1
Moore, J.P.2
-
59
-
-
0028999803
-
Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer
-
Sattentau, Q. J., and J. P. Moore. 1995. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182:185-196.
-
(1995)
J. Exp. Med.
, vol.182
, pp. 185-196
-
-
Sattentau, Q.J.1
Moore, J.P.2
-
60
-
-
0028089320
-
Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated
-
Sawyer, L. S., M. T. Wrin, M. L. Crawford, B. Potts, Y. Wu, P. A. Weber, R. D. Alfonso, and C. V. Hanson. 1994. Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J. Virol. 68:1342-1349.
-
(1994)
J. Virol.
, vol.68
, pp. 1342-1349
-
-
Sawyer, L.S.1
Wrin, M.T.2
Crawford, M.L.3
Potts, B.4
Wu, Y.5
Weber, P.A.6
Alfonso, R.D.7
Hanson, C.V.8
-
61
-
-
0024433219
-
Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV
-
Schawaller, M., G. E. Smith, J. J. Skehel, and D. C. Wiley. 1989. Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. Virology 172:367-369.
-
(1989)
Virology
, vol.172
, pp. 367-369
-
-
Schawaller, M.1
Smith, G.E.2
Skehel, J.J.3
Wiley, D.C.4
-
62
-
-
0027178289
-
Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine
-
Schwartz, D. H., G. Gorse, M. L. Clements, R. Belshe, A. Izu A. M. Duliege, P. Berman, T. Twaddell, D. Stablein, R. Sposto, et al. 1993. Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine. Lancet 342:69-73.
-
(1993)
Lancet
, vol.342
, pp. 69-73
-
-
Schwartz, D.H.1
Gorse, G.2
Clements, M.L.3
Belshe, R.4
Izu, A.5
Duliege, A.M.6
Berman, P.7
Twaddell, T.8
Stablein, D.9
Sposto, R.10
-
64
-
-
0008963824
-
Immunization against yellow fever. Studies on the time of development and the duration of induced immunity
-
Smithburn, K. C., and A. F. Mahaffy. 1945. Immunization against yellow fever. Studies on the time of development and the duration of induced immunity. Am. J. Trop. Med. Hyg. 25:217-223.
-
(1945)
Am. J. Trop. Med. Hyg.
, vol.25
, pp. 217-223
-
-
Smithburn, K.C.1
Mahaffy, A.F.2
-
65
-
-
0026768551
-
Immunization of primates with native, recombinant HIV-SF2 gp120 generates broadly effective neutralizing antibodies directed to conformational epitopes
-
Steimer, K. S., and N. L. Haigwood. 1992. Immunization of primates with native, recombinant HIV-SF2 gp120 generates broadly effective neutralizing antibodies directed to conformational epitopes. AIDS Res. Hum. Retroviruses 8:1391.
-
(1992)
AIDS Res. Hum. Retroviruses
, vol.8
, pp. 1391
-
-
Steimer, K.S.1
Haigwood, N.L.2
-
66
-
-
0011851381
-
Primary isolate neutralizing activity of human antibodies directed to recombinant, native HIV-1 SF2 gp120 (rgp120SF2)
-
Steimer, K. S., D. Sakamoto, D. S. Yi, D. West, J. Baenziger, and F. Sinangil. 1994. Primary isolate neutralizing activity of human antibodies directed to recombinant, native HIV-1 SF2 gp120 (rgp120SF2). J. Cell. Biochem. 18B:114.
-
(1994)
J. Cell. Biochem.
, vol.18 B
, pp. 114
-
-
Steimer, K.S.1
Sakamoto, D.2
Yi, D.S.3
West, D.4
Baenziger, J.5
Sinangil, F.6
-
67
-
-
0026044947
-
Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120
-
Steimer, K. S., C. J. Scandella, P. V. Skiles, and N. L. Haigwood. 1991. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120. Science 254:105-108.
-
(1991)
Science
, vol.254
, pp. 105-108
-
-
Steimer, K.S.1
Scandella, C.J.2
Skiles, P.V.3
Haigwood, N.L.4
-
68
-
-
0025729346
-
Immune reactions against rabies viruses -infection and vaccination
-
Suss, J., and H. Sinnecker. 1991. Immune reactions against rabies viruses -infection and vaccination. Exp. Pathol. 42:1-9.
-
(1991)
Exp. Pathol.
, vol.42
, pp. 1-9
-
-
Suss, J.1
Sinnecker, H.2
-
69
-
-
0027256814
-
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
-
Thali, M., J. P. Moore, C. Furman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski. 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:3978-3988.
-
(1993)
J. Virol.
, vol.67
, pp. 3978-3988
-
-
Thali, M.1
Moore, J.P.2
Furman, C.3
Charles, M.4
Ho, D.D.5
Robinson, J.6
Sodroski, J.7
-
70
-
-
0025835629
-
gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains
-
Thomas, D. J., J. S. Wall, J. F. Hainfeld, M. Kaczorek, F. P. Booy, B. L. Trus, F. A. Eiserling, and A. C. Steven. 1991. gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains. J. Virol. 65: 3797-3803.
-
(1991)
J. Virol.
, vol.65
, pp. 3797-3803
-
-
Thomas, D.J.1
Wall, J.S.2
Hainfeld, J.F.3
Kaczorek, M.4
Booy, F.P.5
Trus, B.L.6
Eiserling, F.A.7
Steven, A.C.8
-
71
-
-
9044241681
-
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
-
Trkola, A., M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J. P. Moore, and H. Katinger. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1100-1108.
-
(1996)
J. Virol.
, vol.70
, pp. 1100-1108
-
-
Trkola, A.1
Purtscher, M.2
Muster, T.3
Ballaun, C.4
Buchacher, A.5
Sullivan, N.6
Srinivasan, K.7
Sodroski, J.8
Moore, J.P.9
Katinger, H.10
-
72
-
-
0029091404
-
Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccines
-
VanCott, T. C., F. R. Bethke, D. S. Burke, R. R. Redfield, and D. L. Birx. 1995. Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccines. J. Immunol. 155:4100-4110.
-
(1995)
J. Immunol.
, vol.155
, pp. 4100-4110
-
-
VanCott, T.C.1
Bethke, F.R.2
Burke, D.S.3
Redfield, R.R.4
Birx, D.L.5
-
73
-
-
0028170783
-
Preferential antibody recognition of structurally distinct HIV-1 gp120 molecules
-
VanCott, T. C., F. R. Bethke, V. Kalyanaraman, D. S. Burke, R. R. Redfield and D. L. Birx. 1994. Preferential antibody recognition of structurally distinct HIV-1 gp120 molecules. J. Acquired Immune Defic. Syndr. 7:1103-1115.
-
(1994)
J. Acquired Immune Defic. Syndr.
, vol.7
, pp. 1103-1115
-
-
VanCott, T.C.1
Bethke, F.R.2
Kalyanaraman, V.3
Burke, D.S.4
Redfield, R.R.5
Birx, D.L.6
-
74
-
-
0030975067
-
Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160
-
VanCott, T. C., J. R. Mascola, R. W. Kaminski, V. Kalyanaraman, P. L. Hallberg, P. R. Burnett, J. T. Ulrich, D. J. Rechtman, and D. L. Birx. 1997. Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160. J. Virol. 71:4319-4330.
-
(1997)
J. Virol.
, vol.71
, pp. 4319-4330
-
-
VanCott, T.C.1
Mascola, J.R.2
Kaminski, R.W.3
Kalyanaraman, V.4
Hallberg, P.L.5
Burnett, P.R.6
Ulrich, J.T.7
Rechtman, D.J.8
Birx, D.L.9
-
75
-
-
0028805926
-
Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1
-
VanCott, T. C., V. R. Polonis, L. D. Loomis, N. L. Michael, P. L. Nara, and D. L. Birx. 1995. Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1. AIDS Res. Hum. Retroviruses 11:1379-1391.
-
(1995)
AIDS Res. Hum. Retroviruses
, vol.11
, pp. 1379-1391
-
-
VanCott, T.C.1
Polonis, V.R.2
Loomis, L.D.3
Michael, N.L.4
Nara, P.L.5
Birx, D.L.6
-
76
-
-
0029017743
-
Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogen
-
VanCott, T. C., S. C. D. Veit, V. Kalyanaraman, P. Earl, and D. L. Birx. 1995. Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogen. J. Immunol. Methods 183:103-117.
-
(1995)
J. Immunol. Methods
, vol.183
, pp. 103-117
-
-
VanCott, T.C.1
Veit, S.C.D.2
Kalyanaraman, V.3
Earl, P.4
Birx, D.L.5
-
77
-
-
0021838099
-
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients
-
Weiss, R. A., P. R. Clapham, P. R. Cheingsong, A. G. Dalgleish, C. A. Carne, I. V. Weller, and R. S. Tedder. 1985. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature 316:69-72.
-
(1985)
Nature
, vol.316
, pp. 69-72
-
-
Weiss, R.A.1
Clapham, P.R.2
Cheingsong, P.R.3
Dalgleish, A.G.4
Carne, C.A.5
Weller, I.V.6
Tedder, R.S.7
-
78
-
-
0028181249
-
Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus
-
Wrin, T., L. Crawford, L. Sawyer, P. Weber, H. W. Sheppard, and C. V. Hanson. 1994. Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus. J. Acquired Immune Defic. Syndr. 7:211-219.
-
(1994)
J. Acquired Immune Defic. Syndr.
, vol.7
, pp. 211-219
-
-
Wrin, T.1
Crawford, L.2
Sawyer, L.3
Weber, P.4
Sheppard, H.W.5
Hanson, C.V.6
-
79
-
-
0028966078
-
Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera
-
Wrin, T., T. P. Loh, J. C. Vennari, H. Schuitemaker, and J. H. Nunberg. 1995. Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol. 69:39-48.
-
(1995)
J. Virol.
, vol.69
, pp. 39-48
-
-
Wrin, T.1
Loh, T.P.2
Vennari, J.C.3
Schuitemaker, H.4
Nunberg, J.H.5
-
80
-
-
0032543555
-
The antigenic structure of the HIV gp120 envelope glycoprotein
-
Wyatt, R., P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson, and J. G. Sodroski. 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705-711.
-
(1998)
Nature
, vol.393
, pp. 705-711
-
-
Wyatt, R.1
Kwong, P.D.2
Desjardins, E.3
Sweet, R.W.4
Robinson, J.5
Hendrickson, W.A.6
Sodroski, J.G.7
|